Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Heart Pump Devices Market Size

ID: MRFR/MED/4576-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Heart Pump Devices Market Research Report: Size, Share, Trend Analysis By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, And Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, and Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, and Others), And By Region - Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Heart Pump Devices Market Infographic
Purchase Options

Heart Pump Devices Size

Heart Pump Devices Market Growth Projections and Opportunities

Sales in the market of heart pump devices globally will reach the pace at 21.5% annually to 2.88 billion dollar in the near future until the end of observation period that is 2032. The Heart Pump Devices Market is controlled by different market variables that are at the very core of the market framework. It's an important tendency - growing amount of people around the world face heart disease. The need for sturdy and effective treatment alternatives, at the tail of the rising rates of heart-related problems marked in the past few years, demands for advanced heart pump devices is a priority.

The Technological breakthroughs; tend to steer the progress of the Mechanical pumps Continuous investigations and innovations in this field will surely bring in better and advanced devices which will end up benefitting the patients by improving the patient outcomes and minimizing the risks. The advent of innovations such as miniaturization, better materials and wireless connectivity has led to the expansion of the market, such that it attracts both health professionals and patients alike.

Influences by Government programs and laws decisively control its dynamics and size of this market. The favorable regulatory environment as well as funding for research and development provides the right atmosphere in which companies can invest in cardiac technologies to improve with time. Furthermore, insurance policies also predispose more doctors to use the equipment, making it reachable to the many patients.

Another big way the environment is changing for the heart pumps device market is the growing competition. Companies entering new market segments also help to promote competition which leads to the development of new ideas and partly results in lowering costs. This in turn means patients and healthcare providers have access to a diverse choice of options, including those that are affordable and readily available making it easier for them to acquire such devices.

The other side of the world, the factors that play the important role for the growth of GDP and healthcare expenditure will drive the heart pump devices market. Economic growth, on the other hand, tends to coincide with an upsurge in spending on healthcare which is in its turn used to ensure the availability of the latest medical technologies. Therefore, a recession might result in budgetary constrain and, therefore, the purchase of heart pump devices in some areas could be low-cost due to financial problems.

Level of information and explaining is the main thing that is affecting cardiac assist devices. Health career is a field that offers a plethora of opportunities for individuals to contribute to the well-being of others. Whether it's through patient care, research, administration, or education, this field offers a wide range of fulfilling career paths. With the increasing amount of knowledge patients have about different available treatment options, the current trend shows that people now are more inclined than ever to prefer technologically superior alternatives that ultimately translate to better quality of life. Partnership with patient advocate organization and educational campaign participants leads to raising awareness and implicit supporting environment that leads to market expansion.

Factors, such as lifestyle modifications along with dietary habits, can be vital in what will be the final results of the heart pump devices market. Identifying sedentary life patterns, unhealthy dietary choices, physical inactivity, and other lifestyle factors is a reason why cardiovascular diseases are spreading steadily across the world.

Heart Pump Devices Market Size Graph
Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Leave a Comment

FAQs

What is the projected market valuation for the Heart Pump Devices Market in 2035?

<p>The projected market valuation for the Heart Pump Devices Market in 2035 is 6314.4 USD Million.</p>

What was the market valuation for the Heart Pump Devices Market in 2024?

<p>The market valuation for the Heart Pump Devices Market in 2024 was 741.16 USD Million.</p>

What is the expected CAGR for the Heart Pump Devices Market from 2025 to 2035?

<p>The expected CAGR for the Heart Pump Devices Market during the forecast period 2025 - 2035 is 21.5%.</p>

Which application segment had the highest valuation in 2024?

<p>In 2024, the application segment for Coronary Artery Disease had the highest valuation at 1980.0 USD Million.</p>

What are the key players in the Heart Pump Devices Market?

<p>Key players in the Heart Pump Devices Market include Abbott, Medtronic, Boston Scientific, and Terumo.</p>

Which device type is projected to have the highest valuation by 2035?

<p>The Left Ventricular Assist Device is projected to have the highest valuation by 2035, reaching 2500.0 USD Million.</p>

What was the valuation for hospitals as an end user in 2024?

The valuation for hospitals as an end user in 2024 was 3157.2 USD Million.

How does the market for Intra-Aortic Balloon Pumps compare to other device types?

In 2024, the Intra-Aortic Balloon Pump had a valuation of 2514.4 USD Million, indicating strong market performance.

What is the projected growth trend for the Heart Pump Devices Market?

The Heart Pump Devices Market is expected to experience robust growth, with a projected valuation increase to 6314.4 USD Million by 2035.

Which end user segment is expected to grow significantly by 2035?

The end user segment for hospitals is expected to grow significantly, reflecting the increasing demand for heart pump devices.

Market Summary

As per MRFR analysis, the Heart Pump Devices Market Size was estimated at USD 741.16 Million in 2024. The Heart Pump Devices industry is projected to grow from USD 900.53 Million in 2025 to USD 6314.4 Million by 2035, exhibiting a compound annual growth rate (CAGR) of 21.5% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Heart Pump Devices Market is experiencing robust growth driven by technological advancements and increasing demand for patient-centric solutions.

  • Technological advancements are reshaping the Heart Pump Devices Market, enhancing device efficiency and patient outcomes. North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for heart pump devices. Heart failure devices dominate the market, whereas total artificial hearts are witnessing the fastest growth in demand. Rising incidence of cardiovascular diseases and increasing investment in healthcare infrastructure are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 741.16 (USD Million)
2035 Market Size 6314.4 (USD Million)
CAGR (2025 - 2035) 21.5%
Largest Regional Market Share in 2024 North America

Major Players

Abbott (US), <a href="https://www.medtronic.com/in-en/patients/treatments-therapies/ventricular-assist-device.html">Medtronic</a> (US), Boston Scientific (US), Terumo (JP), CardiacAssist (US), Getinge (SE), LivaNova (GB), ReliantHeart (US), Cleveland Heart (US)

Market Trends

The Heart Pump Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of cardiovascular diseases. Innovations in device design and functionality are enhancing patient outcomes, while the growing aging population is contributing to a heightened demand for effective heart pump solutions. Furthermore, the integration of telemedicine and remote monitoring capabilities is reshaping how healthcare providers manage patients with heart conditions, potentially leading to improved adherence to treatment protocols and better overall health management. As the Heart Pump Devices Market evolves, regulatory bodies are also adapting to ensure that new devices meet safety and efficacy standards, which may influence the pace of innovation and market entry for new products.

In addition, the Heart Pump Devices Market is witnessing a shift towards minimally invasive procedures, which are often associated with reduced recovery times and lower risk of complications. This trend is likely to attract both patients and healthcare providers seeking efficient treatment options. Moreover, collaborations between medical device manufacturers and technology firms are emerging, suggesting a future where artificial intelligence and machine learning could play a pivotal role in device functionality and patient monitoring. Overall, the Heart Pump Devices Market appears poised for growth, with various factors converging to enhance the landscape of cardiac care.

Technological Advancements

The Heart Pump Devices Market is witnessing rapid technological advancements that enhance device performance and patient outcomes. Innovations such as miniaturization, improved materials, and advanced monitoring systems are becoming increasingly prevalent. These developments not only improve the efficiency of heart pumps but also facilitate better integration with existing healthcare technologies.

Growing Demand for Minimally Invasive Procedures

There is a noticeable shift towards minimally invasive procedures within the Heart Pump Devices Market. Patients and healthcare providers alike are favoring options that reduce recovery time and minimize surgical risks. This trend is likely to drive the development of new devices that align with these preferences, potentially transforming treatment protocols.

Increased Focus on Patient-Centric Solutions

The Heart Pump Devices Market is increasingly focusing on patient-centric solutions, emphasizing personalized treatment plans and improved patient engagement. Manufacturers are exploring ways to incorporate feedback from patients into device design and functionality, which may lead to enhanced satisfaction and adherence to treatment regimens.

Heart Pump Devices Market Market Drivers

Market Growth Projections

The Global Heart Pump Devices Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.74 USD Billion in 2024, it is anticipated to reach 5.6 USD Billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 20.2% from 2025 to 2035. This growth trajectory indicates a strong demand for heart pump devices, driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures. The market's expansion is indicative of the critical role these devices play in modern cardiovascular care.

Rising Healthcare Expenditure

Global healthcare expenditure is on the rise, which positively impacts the Global Heart Pump Devices Market Industry. Increased funding allows for the adoption of advanced medical technologies, including heart pump devices, as healthcare systems strive to improve patient care. With a projected compound annual growth rate (CAGR) of 20.2% from 2025 to 2035, the market is poised for substantial growth. This financial commitment from governments and private sectors facilitates research and development, leading to innovative solutions that address the growing burden of cardiovascular diseases.

Increasing Geriatric Population

The aging population worldwide is a significant factor contributing to the growth of the Global Heart Pump Devices Market Industry. As individuals age, the risk of developing cardiovascular diseases increases, leading to a higher demand for heart pump devices. By 2035, the market is anticipated to expand significantly, driven by the needs of this demographic. The geriatric population often requires specialized care, and heart pump devices provide essential support for managing chronic heart conditions. This demographic shift underscores the necessity for healthcare systems to adapt and invest in advanced heart pump technologies.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Heart Pump Devices Market Industry. As heart-related ailments continue to escalate, the demand for effective treatment options, including heart pump devices, rises correspondingly. With projections indicating that the market will reach 0.74 USD Billion in 2024, healthcare providers are compelled to adopt advanced technologies to manage these conditions. This trend is likely to persist, as cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, necessitating innovative solutions to improve patient outcomes.

Growing Awareness and Education on Heart Health

There is a notable increase in awareness and education regarding heart health, which drives the Global Heart Pump Devices Market Industry. Public health campaigns and educational initiatives are informing individuals about the risks associated with cardiovascular diseases and the available treatment options. As patients become more informed, they are more likely to seek medical intervention, including the use of heart pump devices. This heightened awareness is expected to contribute to the market's growth, as more individuals recognize the importance of early diagnosis and treatment in managing heart conditions.

Technological Advancements in Heart Pump Devices

Technological innovations play a crucial role in shaping the Global Heart Pump Devices Market Industry. The development of miniaturized, more efficient, and biocompatible devices enhances patient comfort and outcomes. For instance, advancements in ventricular assist devices (VADs) have significantly improved their functionality and reliability. As these technologies evolve, they are expected to attract more investment and research, potentially leading to a market valuation of 5.6 USD Billion by 2035. The continuous evolution of these devices indicates a promising future for patients requiring mechanical circulatory support.

Market Segment Insights

By Application: Heart Failure (Largest) vs. Cardiac Surgery (Fastest-Growing)

The Heart Pump Devices Market exhibits diverse application segments, with Heart Failure commanding the largest share. This segment significantly eclipses others, reflecting its pressing clinical need due to the increasing prevalence of heart failure conditions globally. Meanwhile, the Cardiac Surgery segment is capturing attention as the fastest-growing area within the Heart Pump Devices Market, bolstered by advancements in surgical techniques and technology that enhance patient outcomes. This dynamic landscape emphasizes the importance of targeted solutions in managing specific conditions.

Heart Failure (Dominant) vs. Coronary Artery Disease (Emerging)

Heart Failure is recognized as the dominant force in the Heart Pump Devices Market due to its high prevalence and the critical need for effective intervention. The market for heart pumps in this category is characterized by continuous innovation, focusing on improving patient outcomes and ensuring <a href="https://www.marketresearchfuture.com/reports/longevity-market-42067">longevity</a> of the devices. On the other hand, Coronary Artery Disease represents an emerging segment, as advancements in technology are paving the way for more sophisticated treatments. This application is gaining traction due to increasing awareness and the adoption of heart pump solutions aimed at enhancing the quality of life for patients suffering from coronary issues. With a growing pool of clinical studies supporting their effectiveness, both segments are crucial to the overall market dynamics.

By Device Type: Left Ventricular Assist Device (Largest) vs. Intra-Aortic Balloon Pump (Fastest-Growing)

<p>In the Heart Pump Devices Market, the Left Ventricular Assist Device (LVAD) holds a significant share, being the most widely adopted solution for patients with advanced heart failure. The increasing prevalence of heart diseases coupled with technological advancements in LVADs has solidified their position as a preferred treatment option among healthcare providers. Conversely, the Intra-Aortic Balloon Pump (IABP) is gaining traction, aimed primarily at acute coronary syndrome patients, and is recognized for its effectiveness in improving cardiac output and optimizing hemodynamics. As the Heart Pump Devices Market evolves, the LVAD continues to benefit from ongoing research and development, leading to improved device design and patient outcomes. Meanwhile, IABPs are experiencing faster adoption rates due to their minimally invasive nature and cost-effectiveness, making them more accessible. The growing emphasis on patient-centric care and innovative treatments is anticipated to drive further growth in these segments, encouraging a more significant market share for both LVADs and IABPs in the foreseeable future.</p>

<p>Left Ventricular Assist Device (Dominant) vs. Intra-Aortic Balloon Pump (Emerging)</p>

<p>The Left Ventricular Assist Device (LVAD) is a dominant player in the Heart Pump Devices Market, providing critical support for patients suffering from severe heart failure. These devices are designed to take over the pumping function of the left ventricle, allowing patients to maintain a better quality of life while awaiting heart transplants or as a long-term solution for heart failure management. Their established technology, comprehensive clinical backing, and adoption by healthcare systems worldwide highlight their prevalent role in cardiac care. In contrast, the Intra-Aortic Balloon Pump (IABP) represents an emerging segment within this market, gaining popularity due to its ability to augment myocardial perfusion and enhance coronary artery blood flow. With its relatively simple implementation and effectiveness in acute settings, IABPs are becoming increasingly recognized for their potential in enhancing patient outcomes post-cardiac procedures. The growing focus on minimally invasive therapies and advancements in balloon designs further position IABPs as a vital choice for clinicians aiming to optimize cardiac function in critically ill patients.</p>

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Heart Pump Devices Market, hospitals account for the largest share of end users due to their comprehensive healthcare infrastructure and ability to handle complex cardiovascular procedures. They are equipped with advanced technology and specialized medical staff, making them the go-to facilities for heart pump device implantation and management. Ambulatory surgical centers, while smaller in market share compared to hospitals, are becoming increasingly popular owing to their efficiency and ability to provide outpatient care for heart-related procedures.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals maintain a dominant position in the Heart Pump Devices Market, primarily due to their extensive resources, including skilled healthcare professionals, advanced surgical technologies, and a wide range of specialized services. They are typically the preferred choice for patients requiring complex heart procedures, ensuring high-volume utilization of heart pump devices. In contrast, ambulatory surgical centers represent an emerging segment, offering a cost-effective and efficient alternative for specific heart procedures. These centers are gaining traction for their ability to deliver high-quality care in a more convenient setting, increasing their appeal to patients and healthcare providers alike. The shift towards outpatient care indicates a progressive trend in the market.

Get more detailed insights about Heart Pump Devices Market Research Report – Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the Heart Pump Devices market, holding a significant share of 370.58M in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient outcomes and driving market expansion. The competitive landscape in North America is robust, featuring key players such as Abbott, Medtronic, and Boston Scientific. These companies are at the forefront of technological advancements, offering a range of heart pump devices that cater to diverse patient needs. The presence of established healthcare systems and a high level of investment in medical technology contribute to the region's dominance in the global Heart Pump Devices Market.

Europe : Emerging Market with Growth Potential

Europe's Heart Pump Devices market is valued at 220.7M, showcasing a growing demand driven by an aging population and rising awareness of cardiovascular health. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing safety and efficacy standards, which in turn boosts consumer confidence and market growth. The region is witnessing an increase in partnerships between healthcare providers and device manufacturers, facilitating innovation. Leading countries like Germany, France, and the UK are at the forefront of this market, supported by a strong healthcare system and significant investments in medical technology. Key players, including Getinge and LivaNova, are expanding their presence through strategic collaborations and product launches, positioning themselves to capture a larger market share. The competitive landscape is evolving, with a focus on personalized medicine and advanced therapeutic solutions.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific Heart Pump Devices market, valued at 120.0M, is experiencing rapid growth due to increasing healthcare investments and rising incidences of heart diseases. Countries like Japan and China are leading this growth, driven by advancements in medical technology and a growing middle class that demands better healthcare solutions. Regulatory bodies are also becoming more supportive, streamlining approval processes for innovative devices. The competitive landscape is characterized by both global and local players, including Terumo and ReliantHeart, who are focusing on expanding their product offerings. The region's market is witnessing a surge in collaborations and partnerships aimed at enhancing distribution networks and improving access to advanced heart pump technologies. This trend is expected to continue, further propelling market growth in the coming years.

Middle East and Africa : Emerging Market with Challenges

The Heart Pump Devices market in the Middle East and Africa is valued at 20.58M, reflecting a nascent but growing sector. The Heart Pump Devices Market is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. However, challenges such as limited access to advanced medical technologies and varying regulatory environments can hinder growth. Governments are beginning to recognize the importance of cardiovascular health, leading to gradual improvements in healthcare policies. Countries like South Africa and the UAE are emerging as key players in this Heart Pump Devices Market, with investments in healthcare infrastructure and technology. Local and international companies are exploring opportunities to expand their presence, focusing on affordable and effective heart pump solutions. The competitive landscape is still developing, but the potential for growth is significant as awareness and healthcare access improve across the region.

Key Players and Competitive Insights

The Heart Pump Devices Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Abbott (US), Medtronic (US), and Boston Scientific (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Abbott (US) emphasizes the development of next-generation heart pump technologies, while Medtronic (US) is actively pursuing mergers and acquisitions to expand its product portfolio. Boston Scientific (US) is leveraging digital transformation initiatives to improve patient outcomes and streamline operations. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and patient-centric solutions. Key business tactics within the Heart Pump Devices Market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a variety of innovative solutions to emerge, as companies strive to differentiate themselves through unique offerings and enhanced service delivery. In November 2025, Abbott (US) announced the launch of its latest heart pump device, which integrates advanced AI algorithms to monitor patient conditions in real-time. This strategic move is likely to position Abbott as a leader in the Heart Pump Devices Market, as it addresses the growing demand for smart medical devices that enhance patient care and outcomes. The integration of AI not only improves device functionality but also aligns with broader trends towards digital health solutions.
 
In October 2025, Medtronic (US) completed the acquisition of a smaller firm specializing in minimally invasive heart pump technologies. This acquisition is significant as it expands Medtronic's capabilities in a niche segment of the Heart Pump Devices Market, allowing for a more comprehensive product offering. The move reflects Medtronic's commitment to innovation and its strategy to capture a larger share of the growing heart pump market. In September 2025, Boston Scientific (US) entered into a strategic partnership with a leading telehealth provider to enhance remote monitoring capabilities for heart pump patients. This collaboration is indicative of the increasing importance of telehealth solutions in managing chronic conditions. By integrating telehealth with heart pump technologies, Boston Scientific aims to improve patient engagement and adherence to treatment protocols, thereby enhancing overall outcomes. As of December 2025, current competitive trends in the Heart Pump Devices Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming increasingly vital, as companies recognize the need to collaborate to drive innovation and improve patient care. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This transition underscores the importance of not only meeting patient needs but also ensuring that products are sustainable and aligned with the future of healthcare.

Key Companies in the Heart Pump Devices Market include

Industry Developments

December 2022 Abiomed declares The two first patients are enrolled in the Impella ECP Pivotal Trial, which has already received FDA approval for the type of Impella ECP that will be utilized. The operations were directed by Amir Kaki, MD, head of mechanical circulatory support at Ascension St. John Hospital in Detroit.

January 2022 The world's most cutting-edge artificial heart, or Left Ventricular Assist Device (LVAD), is being developed, according to the School of Medical Research and Technology (SMRT), IIT-Kanpur.

Future Outlook

Heart Pump Devices Market Future Outlook

The Heart Pump Devices Market is projected to grow at a 21.5% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

New opportunities lie in:

  • <p>Development of portable heart pump devices for home care settings. Integration of AI for predictive analytics in heart pump management. Expansion into emerging markets with tailored financing solutions.</p>

By 2035, the Heart Pump Devices Market is expected to achieve substantial growth, driven by innovation and strategic market expansion.

Market Segmentation

Heart Pump Devices Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

Heart Pump Devices Market Application Outlook

  • Heart Failure
  • Cardiac Surgery
  • Coronary Artery Disease
  • Myocardial Infarction

Heart Pump Devices Market Device Type Outlook

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Total Artificial Heart
  • Intra-Aortic Balloon Pump

Report Scope

MARKET SIZE 2024 741.16 (USD Million)
MARKET SIZE 2025 900.53 (USD Million)
MARKET SIZE 2035 6314.4 (USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 21.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), CardiacAssist (US), Getinge (SE), LivaNova (GB), ReliantHeart (US), Cleveland Heart (US)
Segments Covered Application, Device Type, End User
Key Market Opportunities Advancements in minimally invasive heart pump technologies enhance patient outcomes and expand market potential.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Heart Pump Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation for the Heart Pump Devices Market in 2035?

<p>The projected market valuation for the Heart Pump Devices Market in 2035 is 6314.4 USD Million.</p>

What was the market valuation for the Heart Pump Devices Market in 2024?

<p>The market valuation for the Heart Pump Devices Market in 2024 was 741.16 USD Million.</p>

What is the expected CAGR for the Heart Pump Devices Market from 2025 to 2035?

<p>The expected CAGR for the Heart Pump Devices Market during the forecast period 2025 - 2035 is 21.5%.</p>

Which application segment had the highest valuation in 2024?

<p>In 2024, the application segment for Coronary Artery Disease had the highest valuation at 1980.0 USD Million.</p>

What are the key players in the Heart Pump Devices Market?

<p>Key players in the Heart Pump Devices Market include Abbott, Medtronic, Boston Scientific, and Terumo.</p>

Which device type is projected to have the highest valuation by 2035?

<p>The Left Ventricular Assist Device is projected to have the highest valuation by 2035, reaching 2500.0 USD Million.</p>

What was the valuation for hospitals as an end user in 2024?

The valuation for hospitals as an end user in 2024 was 3157.2 USD Million.

How does the market for Intra-Aortic Balloon Pumps compare to other device types?

In 2024, the Intra-Aortic Balloon Pump had a valuation of 2514.4 USD Million, indicating strong market performance.

What is the projected growth trend for the Heart Pump Devices Market?

The Heart Pump Devices Market is expected to experience robust growth, with a projected valuation increase to 6314.4 USD Million by 2035.

Which end user segment is expected to grow significantly by 2035?

The end user segment for hospitals is expected to grow significantly, reflecting the increasing demand for heart pump devices.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Million)
    2. | | 4.1.1 Heart Failure
    3. | | 4.1.2 Cardiac Surgery
    4. | | 4.1.3 Coronary Artery Disease
    5. | | 4.1.4 Myocardial Infarction
    6. | 4.2 Healthcare, BY Device Type (USD Million)
    7. | | 4.2.1 Left Ventricular Assist Device
    8. | | 4.2.2 Right Ventricular Assist Device
    9. | | 4.2.3 Total Artificial Heart
    10. | | 4.2.4 Intra-Aortic Balloon Pump
    11. | 4.3 Healthcare, BY End User (USD Million)
    12. | | 4.3.1 Hospitals
    13. | | 4.3.2 Ambulatory Surgical Centers
    14. | | 4.3.3 Home Care Settings
    15. | 4.4 Healthcare, BY Region (USD Million)
    16. | | 4.4.1 North America
    17. | | | 4.4.1.1 US
    18. | | | 4.4.1.2 Canada
    19. | | 4.4.2 Europe
    20. | | | 4.4.2.1 Germany
    21. | | | 4.4.2.2 UK
    22. | | | 4.4.2.3 France
    23. | | | 4.4.2.4 Russia
    24. | | | 4.4.2.5 Italy
    25. | | | 4.4.2.6 Spain
    26. | | | 4.4.2.7 Rest of Europe
    27. | | 4.4.3 APAC
    28. | | | 4.4.3.1 China
    29. | | | 4.4.3.2 India
    30. | | | 4.4.3.3 Japan
    31. | | | 4.4.3.4 South Korea
    32. | | | 4.4.3.5 Malaysia
    33. | | | 4.4.3.6 Thailand
    34. | | | 4.4.3.7 Indonesia
    35. | | | 4.4.3.8 Rest of APAC
    36. | | 4.4.4 South America
    37. | | | 4.4.4.1 Brazil
    38. | | | 4.4.4.2 Mexico
    39. | | | 4.4.4.3 Argentina
    40. | | | 4.4.4.4 Rest of South America
    41. | | 4.4.5 MEA
    42. | | | 4.4.5.1 GCC Countries
    43. | | | 4.4.5.2 South Africa
    44. | | | 4.4.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Medtronic (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Boston Scientific (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Terumo (JP)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 CardiacAssist (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Getinge (SE)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 LivaNova (GB)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 ReliantHeart (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Cleveland Heart (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY DEVICE TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USER
    6. | 6.6 CANADA MARKET ANALYSIS BY APPLICATION
    7. | 6.7 CANADA MARKET ANALYSIS BY DEVICE TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY END USER
    9. | 6.9 EUROPE MARKET ANALYSIS
    10. | 6.10 GERMANY MARKET ANALYSIS BY APPLICATION
    11. | 6.11 GERMANY MARKET ANALYSIS BY DEVICE TYPE
    12. | 6.12 GERMANY MARKET ANALYSIS BY END USER
    13. | 6.13 UK MARKET ANALYSIS BY APPLICATION
    14. | 6.14 UK MARKET ANALYSIS BY DEVICE TYPE
    15. | 6.15 UK MARKET ANALYSIS BY END USER
    16. | 6.16 FRANCE MARKET ANALYSIS BY APPLICATION
    17. | 6.17 FRANCE MARKET ANALYSIS BY DEVICE TYPE
    18. | 6.18 FRANCE MARKET ANALYSIS BY END USER
    19. | 6.19 RUSSIA MARKET ANALYSIS BY APPLICATION
    20. | 6.20 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    21. | 6.21 RUSSIA MARKET ANALYSIS BY END USER
    22. | 6.22 ITALY MARKET ANALYSIS BY APPLICATION
    23. | 6.23 ITALY MARKET ANALYSIS BY DEVICE TYPE
    24. | 6.24 ITALY MARKET ANALYSIS BY END USER
    25. | 6.25 SPAIN MARKET ANALYSIS BY APPLICATION
    26. | 6.26 SPAIN MARKET ANALYSIS BY DEVICE TYPE
    27. | 6.27 SPAIN MARKET ANALYSIS BY END USER
    28. | 6.28 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    29. | 6.29 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    30. | 6.30 REST OF EUROPE MARKET ANALYSIS BY END USER
    31. | 6.31 APAC MARKET ANALYSIS
    32. | 6.32 CHINA MARKET ANALYSIS BY APPLICATION
    33. | 6.33 CHINA MARKET ANALYSIS BY DEVICE TYPE
    34. | 6.34 CHINA MARKET ANALYSIS BY END USER
    35. | 6.35 INDIA MARKET ANALYSIS BY APPLICATION
    36. | 6.36 INDIA MARKET ANALYSIS BY DEVICE TYPE
    37. | 6.37 INDIA MARKET ANALYSIS BY END USER
    38. | 6.38 JAPAN MARKET ANALYSIS BY APPLICATION
    39. | 6.39 JAPAN MARKET ANALYSIS BY DEVICE TYPE
    40. | 6.40 JAPAN MARKET ANALYSIS BY END USER
    41. | 6.41 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    42. | 6.42 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    43. | 6.43 SOUTH KOREA MARKET ANALYSIS BY END USER
    44. | 6.44 MALAYSIA MARKET ANALYSIS BY APPLICATION
    45. | 6.45 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    46. | 6.46 MALAYSIA MARKET ANALYSIS BY END USER
    47. | 6.47 THAILAND MARKET ANALYSIS BY APPLICATION
    48. | 6.48 THAILAND MARKET ANALYSIS BY DEVICE TYPE
    49. | 6.49 THAILAND MARKET ANALYSIS BY END USER
    50. | 6.50 INDONESIA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    52. | 6.52 INDONESIA MARKET ANALYSIS BY END USER
    53. | 6.53 REST OF APAC MARKET ANALYSIS BY APPLICATION
    54. | 6.54 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    55. | 6.55 REST OF APAC MARKET ANALYSIS BY END USER
    56. | 6.56 SOUTH AMERICA MARKET ANALYSIS
    57. | 6.57 BRAZIL MARKET ANALYSIS BY APPLICATION
    58. | 6.58 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    59. | 6.59 BRAZIL MARKET ANALYSIS BY END USER
    60. | 6.60 MEXICO MARKET ANALYSIS BY APPLICATION
    61. | 6.61 MEXICO MARKET ANALYSIS BY DEVICE TYPE
    62. | 6.62 MEXICO MARKET ANALYSIS BY END USER
    63. | 6.63 ARGENTINA MARKET ANALYSIS BY APPLICATION
    64. | 6.64 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    65. | 6.65 ARGENTINA MARKET ANALYSIS BY END USER
    66. | 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    67. | 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    68. | 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    69. | 6.69 MEA MARKET ANALYSIS
    70. | 6.70 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    71. | 6.71 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    72. | 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER
    73. | 6.73 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    74. | 6.74 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    75. | 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER
    76. | 6.76 REST OF MEA MARKET ANALYSIS BY APPLICATION
    77. | 6.77 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    78. | 6.78 REST OF MEA MARKET ANALYSIS BY END USER
    79. | 6.79 KEY BUYING CRITERIA OF HEALTHCARE
    80. | 6.80 RESEARCH PROCESS OF MRFR
    81. | 6.81 DRO ANALYSIS OF HEALTHCARE
    82. | 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    83. | 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    84. | 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
    85. | 6.85 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    86. | 6.86 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    87. | 6.87 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    88. | 6.88 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    89. | 6.89 HEALTHCARE, BY END USER, 2024 (% SHARE)
    90. | 6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    91. | 6.91 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
    5. | | 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    6. | | 7.2.3 BY END USER, 2025-2035 (USD Million)
    7. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    8. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
    9. | | 7.3.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    10. | | 7.3.3 BY END USER, 2025-2035 (USD Million)
    11. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    12. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
    13. | | 7.4.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    14. | | 7.4.3 BY END USER, 2025-2035 (USD Million)
    15. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
    17. | | 7.5.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    18. | | 7.5.3 BY END USER, 2025-2035 (USD Million)
    19. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    20. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
    21. | | 7.6.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    22. | | 7.6.3 BY END USER, 2025-2035 (USD Million)
    23. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
    25. | | 7.7.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    26. | | 7.7.3 BY END USER, 2025-2035 (USD Million)
    27. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
    29. | | 7.8.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    30. | | 7.8.3 BY END USER, 2025-2035 (USD Million)
    31. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    32. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
    33. | | 7.9.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    34. | | 7.9.3 BY END USER, 2025-2035 (USD Million)
    35. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    36. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
    37. | | 7.10.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    38. | | 7.10.3 BY END USER, 2025-2035 (USD Million)
    39. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
    41. | | 7.11.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    42. | | 7.11.3 BY END USER, 2025-2035 (USD Million)
    43. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
    45. | | 7.12.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    46. | | 7.12.3 BY END USER, 2025-2035 (USD Million)
    47. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    48. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
    49. | | 7.13.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    50. | | 7.13.3 BY END USER, 2025-2035 (USD Million)
    51. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
    53. | | 7.14.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    54. | | 7.14.3 BY END USER, 2025-2035 (USD Million)
    55. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    56. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
    57. | | 7.15.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    58. | | 7.15.3 BY END USER, 2025-2035 (USD Million)
    59. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    60. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
    61. | | 7.16.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    62. | | 7.16.3 BY END USER, 2025-2035 (USD Million)
    63. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
    65. | | 7.17.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    66. | | 7.17.3 BY END USER, 2025-2035 (USD Million)
    67. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    68. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
    69. | | 7.18.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    70. | | 7.18.3 BY END USER, 2025-2035 (USD Million)
    71. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    72. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
    73. | | 7.19.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    74. | | 7.19.3 BY END USER, 2025-2035 (USD Million)
    75. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
    77. | | 7.20.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    78. | | 7.20.3 BY END USER, 2025-2035 (USD Million)
    79. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    80. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
    81. | | 7.21.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    82. | | 7.21.3 BY END USER, 2025-2035 (USD Million)
    83. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
    85. | | 7.22.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    86. | | 7.22.3 BY END USER, 2025-2035 (USD Million)
    87. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
    89. | | 7.23.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    90. | | 7.23.3 BY END USER, 2025-2035 (USD Million)
    91. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    92. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
    93. | | 7.24.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    94. | | 7.24.3 BY END USER, 2025-2035 (USD Million)
    95. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    96. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
    97. | | 7.25.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    98. | | 7.25.3 BY END USER, 2025-2035 (USD Million)
    99. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
    101. | | 7.26.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    102. | | 7.26.3 BY END USER, 2025-2035 (USD Million)
    103. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
    105. | | 7.27.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    106. | | 7.27.3 BY END USER, 2025-2035 (USD Million)
    107. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    108. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
    109. | | 7.28.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    110. | | 7.28.3 BY END USER, 2025-2035 (USD Million)
    111. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
    113. | | 7.29.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    114. | | 7.29.3 BY END USER, 2025-2035 (USD Million)
    115. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    116. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
    117. | | 7.30.2 BY DEVICE TYPE, 2025-2035 (USD Million)
    118. | | 7.30.3 BY END USER, 2025-2035 (USD Million)
    119. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    120. | | 7.31.1
    121. | 7.32 ACQUISITION/PARTNERSHIP
    122. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Heart Failure
  • Cardiac Surgery
  • Coronary Artery Disease
  • Myocardial Infarction

Healthcare By Device Type (USD Million, 2025-2035)

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Total Artificial Heart
  • Intra-Aortic Balloon Pump

Healthcare By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions